We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
+5.56%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$14.4B
AUM Growth
+$580M
Cap. Flow
-$102M
Cap. Flow %
-0.7%
Top 10 Hldgs %
30.89%
Holding
368
New
16
Increased
155
Reduced
158
Closed
9

Top Buys

Rank Stock Value
1
ADP icon
Automatic Data Processing
ADP
+$64.6M
2
LLY icon
Eli Lilly
LLY
+$31.3M
3
MDLZ icon
Mondelez International
MDLZ
+$25.7M
4
AVGO icon
Broadcom
AVGO
+$21.7M
5
PSX icon
Phillips 66
PSX
+$11.8M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$45.1M
2
HPQ icon
HP
HPQ
+$40M
3
NEE icon
NextEra Energy
NEE
+$33M
4
PAYX icon
Paychex
PAYX
+$25.1M
5
CSCO icon
Cisco
CSCO
+$19.9M

Sector Composition

Rank Sector Weight
1 Technology 19.25%
2 Financials 16.25%
3 Healthcare 12.13%
4 Consumer Staples 10.11%
5 Industrials 9.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EGOV
201
DELISTED
NIC Inc
EGOV
$2.88M 0.02%
129,100
-300
-0.2% -$6.57K
EFA icon
202
iShares MSCI EAFE ETF
EFA
$79.4B
$2.84M 0.02%
40,886
+633
+2% +$42.8K
AVNT icon
203
Avient
AVNT
$3.48B
$2.79M 0.02%
75,976
-6,410
-8% -$209K
DUK icon
204
Duke Energy
DUK
$96.2B
$2.78M 0.02%
30,465
+111
+0.4% +$10.2K
HRC
205
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$2.78M 0.02%
24,470
RBA icon
206
RB Global
RBA
$17.8B
$2.77M 0.02%
64,399
+181
+0.3% +$7.54K
KR icon
207
Kroger
KR
$34.7B
$2.76M 0.02%
95,316
-8,971
-9% -$238K
NI icon
208
NiSource
NI
$20.6B
$2.74M 0.02%
98,550
+1,974
+2% +$54.1K
PAG icon
209
Penske Automotive Group
PAG
$14.2B
$2.74M 0.02%
+54,533
New +$2.7M
GWW icon
210
W.W. Grainger
GWW
$60.7B
$2.7M 0.02%
7,968
TMO icon
211
Thermo Fisher Scientific
TMO
$214B
$2.69M 0.02%
8,265
-334
-4% -$101K
WST icon
212
West Pharmaceutical
WST
$24.7B
$2.67M 0.02%
17,758
-832
-4% -$121K
PRGS icon
213
Progress Software
PRGS
$1.73B
$2.61M 0.02%
62,929
+233
+0.4% +$9.46K
TXRH icon
214
Texas Roadhouse
TXRH
$13.7B
$2.57M 0.02%
45,670
-24
-0.1% -$1.32K
UFPI icon
215
UFP Industries
UFPI
$5.24B
$2.51M 0.02%
52,654
+114
+0.2% +$5.37K
T icon
216
AT&T
T
$158B
$2.51M 0.02%
85,060
-4,738
-5% -$137K
RDS.A
217
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$2.42M 0.02%
41,053
-552
-1% -$32.2K
ATRI
218
DELISTED
Atrion Corp
ATRI
$2.35M 0.02%
3,131
+18
+0.6% +$13.6K
RUTH
219
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
$2.31M 0.02%
105,979
+79,605
+302% +$1.75M
CPK icon
220
Chesapeake Utilities
CPK
$3.21B
$2.28M 0.02%
23,802
-36
-0.2% -$3.35K
SCL icon
221
Stepan Co
SCL
$1.46B
$2.27M 0.02%
22,212
+35
+0.2% +$3.41K
BLKB icon
222
Blackbaud
BLKB
$2.08B
$2.27M 0.02%
28,471
+2
+0% +$167
SHW icon
223
Sherwin-Williams
SHW
$89.7B
$2.23M 0.02%
11,448
+2,256
+25% +$430K
POWI icon
224
Power Integrations
POWI
$3.45B
$2.23M 0.02%
45,014
+400
+0.9% +$18.4K
AZTA icon
225
Azenta
AZTA
$1.47B
$2.21M 0.02%
52,712
+616
+1% +$25.9K

Similar funds

Bahl & Gaynor's Q4 2019 Portfolio in Review

As of Q4 2019, Bahl & Gaynor held 368 positions worth $14.4B, up 4.2% from $13.8B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Bahl & Gaynor's Q4 2019 filing shows 16 new, 155 increased, 158 reduced and 9 closed positions. Its largest new stake was Penske Automotive Group: 54,533 shares worth $2.74M. The largest sale was Pfizer, an estimated $45.1M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • Bahl & Gaynor's largest Q4 2019 buy was Penske Automotive Group: 54,533 shares worth $2.74M.
  • Bahl & Gaynor added most to Automatic Data Processing in Q4 2019, an estimated $64.6M increase.
  • Bahl & Gaynor's biggest Q4 2019 reduction was Pfizer, cutting an estimated $45.1M.
  • Bahl & Gaynor fully exited KLA in Q4 2019, selling an estimated $3.18M.
  • Bahl & Gaynor's ten largest holdings make up 31% of its $14.4B portfolio in Q4 2019.
  • Bahl & Gaynor opened 16 new positions and closed 9 in Q4 2019.
  • Bahl & Gaynor's portfolio value rose 4.2% quarter-over-quarter to $14.4B.

Based on Bahl & Gaynor's 13F filing for Q4 2019, filed 14 Feb 2020.